Select Equity Group’s Globus Medical GMED Stock Holding History

Select Equity Group’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-626,640	Closed	-$51.8M	–	161
2024 Q4	$51.8M	Sell	626,640 -656,214	-51%	-$51.8M	0.21%	74
2024 Q3	$91.8M	Sell	1,282,854 -56,188	-4%	-$3.97M	0.33%	60
2024 Q2	$91.7M	Buy	+1,339,042	New	+$80M	0.36%	59
2023 Q3	–	Sell	-547,335	Closed	-$32.6M	–	178
2023 Q2	$32.6M	Buy	+547,335	New	+$31.2M	0.12%	96
2016 Q4	–	Sell	-1,023,238	Closed	-$23.1M	–	91
2016 Q3	$23.1M	Sell	1,023,238 -82,639	-7%	-$1.94M	0.2%	78
2016 Q2	$26.4M	Sell	1,105,877 -756,193	-41%	-$18.1M	0.23%	72
2016 Q1	$44.2M	Buy	1,862,070 +332,637	+22%	+$8.13M	0.37%	60
2015 Q4	$42.5M	Buy	+1,529,433	New	+$38.4M	0.41%	58
2015 Q2	–	Sell	-89,404	Closed	-$2.26M	–	105
2015 Q1	$2.26M	Buy	+89,404	New	+$2.18M	0.02%	101

Other funds holding GMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAM

Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Select Equity Group's GMED Position: Q1 2025 in Review

Select Equity Group sold out of Globus Medical (GMED) in Q1 2025, closing a stake of 626,640 shares — an estimated $51.8M sold.

Select Equity Group first reported a position in GMED in Q1 2015 and held it in 9 quarters. The position peaked at $91.8M in Q3 2024. 514 funds tracked by Wall St. Rank hold GMED as of Q1 2025.

Select Equity Group reported no remaining Globus Medical position as of Q1 2025 after selling out during the quarter.
Select Equity Group sold 626,640 Globus Medical shares in Q1 2025, an estimated $51.8M.
Select Equity Group first reported a position in Globus Medical in Q1 2015 and held it in 9 quarters.
Select Equity Group's Globus Medical position peaked at $91.8M in Q3 2024.
514 funds tracked by Wall St. Rank held Globus Medical as of Q1 2025.

Based on Select Equity Group's 13F filing for Q1 2025, filed 15 May 2025.